- In a momentous vote for Pelosi, House sends drug pricing reforms to President Biden’s deskby Rachel Cohrs on August 12, 2022
- WHO renames lineages of monkeypox, moving away from geographic linksby Andrew Joseph on August 12, 2022
- Wastewater monitoring identifies polioviruses in New York Cityby Helen Branswell on August 12, 2022
- STAT+: Up and down the ladder: The latest comings and goingsby Ed Silverman on August 12, 2022
- STAT+: Pharmalittle: Two children died after getting Novartis gene therapy; monkeypox vaccine maker warns about splitting dosesby Ed Silverman on August 12, 2022
- Opinion: Medicare cuts would undermine the movement to increasing in-home careby Krista Drobac on August 12, 2022
- Opinion: Psychedelics researchers and investors should focus on delivering therapy, not drugsby Michael Pollack on August 12, 2022
- New data from several states show racial disparities in monkeypox infectionsby Usha Lee McFarling and Katherine Gilyard and Akila Muthukumar on August 11, 2022
- STAT+: Wyden wants details on Amgen’s U.S. taxes as part of expanding probe into pharma practicesby Ed Silverman on August 11, 2022
- STAT+: Novartis reports two children died from acute liver failure after treatment with Zolgensma gene therapyby Ed Silverman on August 11, 2022
- The latest on breakthrough devices, crowdsourced monkeypox support, & VA’s stumble on digital divideby Mohana Ravindranath on August 11, 2022
- Listen: Big egos in Big Science, the return of Merger Monday, & the fallout over drug pricingby Damian Garde and Allison DeAngelis and Adam Feuerstein on August 11, 2022
- CDC eases Covid-19 quarantine and testing guidelines as it marks a new phase in pandemicby Andrew Joseph on August 11, 2022
- ‘Window dressing’: Eli Lilly’s after-the-fact statement on Indiana’s abortion law sends a disingenuous messageby Ed Silverman on August 11, 2022
- STAT+: One Medical’s dueling offers from Amazon and CVS signal a start to health tech bidding warsby Bob Herman and Katie Palmer on August 11, 2022
- Democrats’ TGIF moment, pathologists defend their turf, & Biogen’s back at the FDA’s doorstepby Elissa Welle on August 11, 2022
- STAT+: Pharmalittle: Judge rules Walgreens helped fuel San Francisco opioid crisis; U.S. plan to bottle monkeypox vaccine could take monthsby Ed Silverman on August 11, 2022
- Opinion: FDA needs to fully review ACAM2000 before allowing its widespread use as a monkeypox vaccineby Caitlin Rivers and Tom Inglesby on August 11, 2022
- STAT+: Federal judge dismisses doctor’s case that argued surprise billing law was unconstitutionalby Bob Herman on August 11, 2022
- Opinion: Why don’t they just do what the evidence says? The challenge and promise of implementation scienceby Mark S. Bauer on August 11, 2022